Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat in Patients With Septic Coagulopathy
NCT07214103Phase 2Not yet recruiting
- Sponsor
- Strasbourg University Hospital
- Start
- Aug 2027
- Primary completion
- Aug 2032
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sivelestat in septic shock, coagulopathy, sponsored by Strasbourg University Hospital. Planned start Aug 2027; status: not yet recruiting.
02
Drugs
sivelestat
03
Conditions
septic shockcoagulopathy
Beyond the preview
Go deeper on NCT07214103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07214103.